We are live on ! Find out more
DCM

DG Capital Management Portfolio holdings

AUM $326M
1-Year Est. Return 39.67%
This Fund
S&P 500
This Quarter Est. Return
-11.18%
1 Year Est. Return
+39.67%
3 Year Est. Return
+81.23%
5 Year Est. Return
+56.79%
10 Year Est. Return
AUM
$183M
AUM Growth
-$41.5M
Cap. Flow
-$21.6M
Cap. Flow %
-11.79%
Top 10 Hldgs %
76.88%
Holding
38
New
2
Increased
10
Reduced
4
Closed
12

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$8.37M
2
VEON icon
VEON
VEON
+$4.14M
3
HTZ icon
Hertz
HTZ
+$2.77M
4
CYH icon
Community Health Systems
CYH
+$2.61M
5
THC icon
Tenet Healthcare
THC
+$2.27M

Sector Composition

Rank Sector Weight
1 Healthcare 31.59%
2 Consumer Discretionary 26%
3 Industrials 12.06%
4 Communication Services 7.18%
5 Financials 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATEX icon
26
Anterix
ATEX
$1.81B
-128,672
Closed -$4.08M
BUR icon
27
PUT
Burford Capital
BUR
$903M
-33,600
Closed -$409K
CYH icon
28
CALL
Community Health Systems
CYH
$393M
-100,000
Closed -$440K
CZR icon
29
PUT
Caesars Entertainment
CZR
$6.06B
-155,000
Closed -$7.9M
SPHR icon
30
Sphere Entertainment
SPHR
$5.14B
-39,818
Closed -$1.09M
SPY icon
31
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
-23,500
Closed -$10.4M
TPB icon
32
Turning Point Brands
TPB
$1.45B
-255,644
Closed -$6.14M
UTHR icon
33
CALL
United Therapeutics
UTHR
$25.8B
-6,000
Closed -$1.32M
SUM
34
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-75,135
Closed -$2.84M
ICPT
35
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-74,300
Closed -$822K
ICPT
36
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-896,294
Closed -$9.91M

Similar funds

DG Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, DG Capital Management held 38 positions worth $183M, down 18% from $224M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

DG Capital Management withdrew a net $21.6M in Q3 2023, closing 12 positions and reducing 4 holdings. Its most notable exit was Intercept Pharmaceuticals, Inc., an estimated $9.91M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, DG Capital Management added an estimated $8.37M to United Therapeutics.

  • DG Capital Management added most to United Therapeutics in Q3 2023, an estimated $8.37M increase.
  • DG Capital Management's biggest Q3 2023 reduction was Burford Capital, cutting an estimated $2.07M.
  • DG Capital Management fully exited Intercept Pharmaceuticals, Inc. in Q3 2023, selling an estimated $9.91M.
  • DG Capital Management's ten largest holdings make up 77% of its $183M portfolio in Q3 2023.
  • DG Capital Management opened 2 new positions and closed 12 in Q3 2023.
  • DG Capital Management's portfolio value fell 18% quarter-over-quarter to $183M.

Based on DG Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.